Murray McKinnon

Title: Innovations by Inventor Murray McKinnon

Introduction

Murray McKinnon, a notable inventor based in Washington Crossing, PA, holds a commendable portfolio of seven patents. His innovative contributions primarily focus on biopharmaceuticals, particularly in targeting immune responses through domain antibodies.

Latest Patents

Among his recent inventions, one of the significant patents titled "Compositions Monovalent for CD28 Binding and Methods of Use" stands out. This patent discloses domain antibodies that can monovalently bind to CD28, effectively inhibiting its activity. Specific aspects highlight that these domain antibodies consist of a single immunoglobulin variable domain that specifically antagonizes CD28 without substantially activating it. Furthermore, the patent encompasses methods to antagonize interactions between CD80 and CD86 with CD28, aimed at treating various diseases associated with these interactions.

Career Highlights

Murray McKinnon has made substantial strides in the biopharmaceutical industry, contributing his expertise through roles at Bristol-Myers Squibb Company and Domantis Limited. His work at these esteemed organizations has allowed him to advance his research and development in immunology and antibody engineering.

Collaborations

Throughout his career, Murray has collaborated with distinguished professionals, including Steven G. Nadler and Suzanne J. Suchard. These collaborations have played a crucial role in enriching his research and enhancing the impact of his inventions in the medical field.

Conclusion

Murray McKinnon's innovative work and patents significantly contribute to the medical and biotechnological domains. His commitment to advancing immunological therapies holds promise for improving treatments for various diseases, showcasing the essence of innovation in science.